JP2011516032A5 - - Google Patents

Download PDF

Info

Publication number
JP2011516032A5
JP2011516032A5 JP2010548899A JP2010548899A JP2011516032A5 JP 2011516032 A5 JP2011516032 A5 JP 2011516032A5 JP 2010548899 A JP2010548899 A JP 2010548899A JP 2010548899 A JP2010548899 A JP 2010548899A JP 2011516032 A5 JP2011516032 A5 JP 2011516032A5
Authority
JP
Japan
Prior art keywords
mir
gastric cancer
composition
biomarker
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010548899A
Other languages
English (en)
Japanese (ja)
Other versions
JP5662166B2 (ja
JP2011516032A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/035458 external-priority patent/WO2009108853A1/en
Publication of JP2011516032A publication Critical patent/JP2011516032A/ja
Publication of JP2011516032A5 publication Critical patent/JP2011516032A5/ja
Application granted granted Critical
Publication of JP5662166B2 publication Critical patent/JP5662166B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010548899A 2008-02-28 2009-02-27 胃癌の診断、予後診断及び治療のためのマイクロｒｎａに基づいた方法及び組成物 Expired - Fee Related JP5662166B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6744508P 2008-02-28 2008-02-28
US61/067,445 2008-02-28
PCT/US2009/035458 WO2009108853A1 (en) 2008-02-28 2009-02-27 MicroRNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF GASTRIC CANCER

Publications (3)

Publication Number Publication Date
JP2011516032A JP2011516032A (ja) 2011-05-26
JP2011516032A5 true JP2011516032A5 (https=) 2013-03-21
JP5662166B2 JP5662166B2 (ja) 2015-01-28

Family

ID=41016479

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010548899A Expired - Fee Related JP5662166B2 (ja) 2008-02-28 2009-02-27 胃癌の診断、予後診断及び治療のためのマイクロｒｎａに基づいた方法及び組成物

Country Status (7)

Country Link
US (1) US20110034538A1 (https=)
EP (2) EP2257647B1 (https=)
JP (1) JP5662166B2 (https=)
CN (1) CN102007223B (https=)
AU (1) AU2009219190A1 (https=)
CA (1) CA2716906A1 (https=)
WO (1) WO2009108853A1 (https=)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5489459B2 (ja) 2005-08-01 2014-05-14 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 乳癌の診断、予後及び治療のためのマイクロｒｎａに基づいた方法及び組成物
CA2845251A1 (en) 2005-09-12 2007-03-22 The Ohio State University Research Foundation Compositions for the therapy of bcl2-associated cancers and methods of preparation thereof
JP5490413B2 (ja) 2006-01-05 2014-05-14 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 膵内分泌腫瘍及び膵腺房腫瘍におけるマイクロｒｎａ発現異常
EP2487258B1 (en) 2006-01-05 2014-10-01 The Ohio State University Research Foundation MicroRNA-based methods for the diagnosis of colon, pancreas and stomach cancer
CN102943108B (zh) 2006-01-05 2014-05-21 俄亥俄州立大学研究基金会 用于肺癌的诊断、预后和治疗的基于微小rna的方法和组合物
ES2446362T3 (es) 2006-03-20 2014-03-07 The Ohio State University Research Foundation Huellas de microARN durante megacariocipoyesis humana
CA2657030A1 (en) 2006-07-13 2008-01-17 The Ohio State University Research Foundation, An Instrumentality Of The State Of Ohio Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases
CN101535505A (zh) 2006-09-19 2009-09-16 俄亥俄州立大学研究基金会 慢性淋巴细胞性白血病(CLL)中受miR-29和miR-181调控的TCL1的表达
EP2087135B8 (en) 2006-11-01 2013-07-24 The Ohio State University Research Foundation Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
CN105256004A (zh) 2007-01-31 2016-01-20 俄亥俄州立大学研究基金会 用于急性髓细胞白血病(aml)的诊断、预后和治疗的基于微rna的方法和组合物
ES2527648T3 (es) 2007-06-08 2015-01-28 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Métodos para determinar el subtipo de carcinoma hepatocelular
EP2719773A3 (en) 2007-06-15 2014-07-30 The Ohio State University Research Foundation miRNA as marker for acute lamphomic leucemia
ES2496172T3 (es) 2007-07-31 2014-09-18 The Ohio State University Research Foundation Métodos para invertir la metilación por selección dirigida de DNMT3A y DNMT3B
JP2010535473A (ja) 2007-08-03 2010-11-25 ズィ、オハイオウ、ステイト、ユーニヴァーサティ、リサーチ、ファウンデイシャン ｎｃＲＮＡをコードする超保存領域
CA2696887C (en) 2007-08-22 2016-06-28 The Ohio State University Research Foundation Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias
CN102137927B (zh) 2007-10-26 2014-03-12 俄亥俄州立大学研究基金会 鉴定脆性组氨酸三联体(Fhit)相互作用的方法及其用途
ES2433940T3 (es) 2008-06-11 2013-12-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Uso de la familia miR-26 como marcador predictivo del carcinoma hepatocelular y sensibilidad a la terapia
US8916533B2 (en) 2009-11-23 2014-12-23 The Ohio State University Materials and methods useful for affecting tumor cell growth, migration and invasion
WO2012010584A1 (en) * 2010-07-20 2012-01-26 Febit Holding Gmbh Complex mirna sets as novel biomarkers for gastric cancer
JP5931897B2 (ja) 2010-11-12 2016-06-08 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイションＴｈｅ Ｏｈｉｏ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ マイクロｒｎａ−２１、ミスマッチ修復および結腸直腸癌に関連する物質および方法
CA2817982C (en) 2010-11-15 2020-06-30 The Regents Of The University Of Michigan Controlled release mucoadhesive systems
SG182016A1 (en) * 2010-12-14 2012-07-30 Univ Singapore Method of detecting resistance to cancer therapy
WO2012122239A1 (en) 2011-03-07 2012-09-13 The Ohio State University MUTATOR ACTIVITY INDUCED BY MICRORNA-155 (miR-155) LINKS INFLAMMATION AND CANCER
CA2833389C (en) * 2011-04-18 2022-01-11 Diamir, Llc Mirna-based universal screening test (ust)
US8703425B2 (en) * 2011-09-12 2014-04-22 The Chinese University Of Hong Kong Biomarker for gastric cancer
GB201117482D0 (en) * 2011-10-11 2011-11-23 Univ Dundee Targetiing of miRNA precursors
AU2012323924A1 (en) 2011-10-14 2014-05-29 The Ohio State University Methods and materials related to ovarian cancer
CA2859430A1 (en) 2011-12-13 2013-06-20 Ohio State Innovation Foundation Methods and compositions related to mir-21 and mir-29a, exosome inhibition, and cancer metastasis
US8859202B2 (en) 2012-01-20 2014-10-14 The Ohio State University Breast cancer biomarker signatures for invasiveness and prognosis
WO2014028762A1 (en) * 2012-08-15 2014-02-20 University Of Virginia Patent Foundation Compositions and methods for treating peripheral arterial disease
WO2014097875A1 (ja) * 2012-12-20 2014-06-26 国立大学法人鳥取大学 新規の脱分化誘導方法を用いた多能性幹細胞化
CN106460068B (zh) 2014-06-16 2024-08-23 东丽株式会社 胃癌的检测试剂盒或装置以及检测方法
CN104013975A (zh) * 2014-06-16 2014-09-03 山东大学 Fbxo31基因及其相关产物在制备胃癌治疗药物中的应用
EP4137586B1 (en) 2014-08-07 2026-04-22 Agency for Science, Technology and Research Microrna biomarker for the diagnosis of gastric cancer
CN104293923A (zh) * 2014-09-19 2015-01-21 浙江大学 荧光定量PCR检测组织中miR-100含量的试剂盒及其应用
CN106591428B (zh) * 2016-09-23 2021-06-11 宁波大学 一种胃癌新型分子标记物hsa_circ_0001017的检测及应用
CN106636334B (zh) * 2016-10-09 2020-07-03 山东大学 microRNA标志物组及其在制备检测胃癌淋巴结转移试剂盒中的应用
CN106755513B (zh) * 2017-02-08 2018-10-19 泰山医学院 一种胃癌的lncRNA标志物
US11576873B2 (en) 2017-03-31 2023-02-14 The Curators Of The University Of Missouri Compositions for the treatment of drug-resistant tumors and methods of use thereof
CN107217055B (zh) * 2017-06-26 2019-01-18 生工生物工程（上海）股份有限公司 一种癌症诊断芯片及其试剂盒
CN107641653B (zh) * 2017-10-20 2021-02-19 南方医科大学南方医院 Macc1-as1探针在制备用于预测胃癌临床预后的诊断试剂中的应用
CN108546757B (zh) * 2018-03-05 2021-09-07 上海长海医院 Zfpm2-as1在制备胃癌诊断试剂或试剂盒中的应用
KR102100124B1 (ko) * 2018-08-31 2020-05-15 한국표준과학연구원 질량 분석법을 이용한 생체 분자의 고감도 및 고특이적 검출 방법
SG11202106638UA (en) * 2018-12-19 2021-07-29 Agency Science Tech & Res Method of diagnosing gastric cancers using micrornas
CN117683885A (zh) * 2019-04-30 2024-03-12 觅瑞实验室私人有限公司 一种检测胃癌的miRNA标志物组合及试剂盒
CN111471764B (zh) * 2019-12-27 2023-09-15 陈锦飞 一种用于筛查或辅助诊断胃癌的生物标志物组合及其试剂盒和应用
CN111139299B (zh) * 2020-01-08 2021-12-17 浙江大学 Josd2蛋白在制备治疗恶性肿瘤药物中的应用
CN111471683B (zh) * 2020-04-15 2021-09-07 湖南省科域生物医药科技有限公司 miR-93-5p作为诊断和治疗胃癌标志物的应用
CN114678121B (zh) * 2022-05-30 2022-09-09 上海芯超生物科技有限公司 一种hp球形变诊断模型的构建方法及系统
WO2025245056A1 (en) * 2024-05-20 2025-11-27 City Of Hope Gastric cancer rna biomarkers and uses thereof

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1837495A (en) * 1994-10-13 1996-05-06 Horus Therapeutics, Inc. Computer assisted methods for diagnosing diseases
US6303323B1 (en) * 1997-10-21 2001-10-16 Cancer Research Campaign Technology Limited Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
US6891031B2 (en) * 2000-02-18 2005-05-10 The Regents Of The University Of California Coordinate cytokine regulatory sequences
US7455995B2 (en) * 2001-11-09 2008-11-25 The Ohio State University Research Foundation BAALC expression as a diagnostic marker for acute leukemia
AU2002231843A1 (en) * 2002-02-12 2003-09-04 Nokia Corporation Method for controlling data transmission, and data transmission system
WO2004071464A2 (en) * 2003-02-12 2004-08-26 Johns Hopkins University School Of Medicine Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells
US20050069918A1 (en) * 2003-05-29 2005-03-31 Francois Claret JAB1 as a prognostic marker and a therapeutic target for human cancer
US8106180B2 (en) * 2003-08-07 2012-01-31 Whitehead Institute For Biomedical Research Methods and products for expression of micro RNAs
US20050164252A1 (en) * 2003-12-04 2005-07-28 Yeung Wah Hin A. Methods using non-genic sequences for the detection, modification and treatment of any disease or improvement of functions of a cell
US20060134639A1 (en) * 2004-04-06 2006-06-22 Huffel Christophe V Method for the determination of cellular transcriptional regulation
CN101056991A (zh) * 2004-04-20 2007-10-17 基因耐克生物医学制品有限公司 检测ncRNA的方法
EP2290071B1 (en) * 2004-05-28 2014-12-31 Asuragen, Inc. Methods and compositions involving microRNA
KR20070058441A (ko) * 2004-07-01 2007-06-08 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 면역억제성 엑소솜
JP2008511678A (ja) * 2004-09-02 2008-04-17 イェール ユニバーシティ マイクロｒｎａによるオンコジーンの調節
US7642348B2 (en) * 2004-10-04 2010-01-05 Rosetta Genomics Ltd Prostate cancer-related nucleic acids
US7571055B2 (en) * 2004-10-13 2009-08-04 Regents Of The University Of Minnesota Systemic lupus erythematosus
CA2857881A1 (en) * 2004-11-12 2006-12-28 Asuragen, Inc. Methods and compositions involving mirna and mirna inhibitor molecules
US8071306B2 (en) * 2005-01-25 2011-12-06 Merck Sharp & Dohme Corp. Methods for quantitating small RNA molecules
CA2597767A1 (en) * 2005-02-11 2006-08-17 Wisconsin Alumni Research Foundation Mir-155 assay
US20070213292A1 (en) * 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
US20070092882A1 (en) * 2005-10-21 2007-04-26 Hui Wang Analysis of microRNA
US8445198B2 (en) * 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
JP5490413B2 (ja) * 2006-01-05 2014-05-14 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 膵内分泌腫瘍及び膵腺房腫瘍におけるマイクロｒｎａ発現異常
CN102943108B (zh) * 2006-01-05 2014-05-21 俄亥俄州立大学研究基金会 用于肺癌的诊断、预后和治疗的基于微小rna的方法和组合物
EP2487258B1 (en) * 2006-01-05 2014-10-01 The Ohio State University Research Foundation MicroRNA-based methods for the diagnosis of colon, pancreas and stomach cancer
CA2648132C (en) * 2006-04-03 2019-05-28 Santaris Pharma A/S Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
CA2657030A1 (en) * 2006-07-13 2008-01-17 The Ohio State University Research Foundation, An Instrumentality Of The State Of Ohio Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases
JP2010510964A (ja) * 2006-09-19 2010-04-08 アシュラジェン インコーポレイテッド 治療的介入の標的としての、ｍｉＲ−１５、ｍｉＲ−２６、ｍｉＲ−３１、ｍｉＲ−１４５、ｍｉＲ−１４７、ｍｉＲ−１８８、ｍｉＲ−２１５、ｍｉＲ−２１６、ｍｉＲ−３３１、ｍｍｕ−ｍｉＲ−２９２−３ｐによって調節される遺伝子および経路
WO2008073920A2 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Mir-21 regulated genes and pathways as targets for therapeutic intervention
CA2699418A1 (en) * 2007-02-27 2008-09-04 Moshe Oren Composition and methods for modulating cell proliferation and cell death
EP2126584B1 (en) * 2007-03-16 2012-12-19 CovalX AG Direct mass spectrometric analysis of drug candidates targeting protein complexes
WO2009015357A1 (en) * 2007-07-25 2009-01-29 University Of Louisville Research Foundation, Inc. Exosome-associated microrna as a diagnostic marker
CA2696887C (en) * 2007-08-22 2016-06-28 The Ohio State University Research Foundation Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias
US20090239818A1 (en) * 2007-09-07 2009-09-24 Cheng Jin Q Effective treatment of ovarian cancer using triciribine and related compounds
US20100305188A1 (en) * 2007-10-03 2010-12-02 Kyowa Hakko Kirin Co., Ltd. Nucleic acid capable of regulating the proliferation of cell
EP2623599B1 (en) * 2007-10-04 2019-01-02 Roche Innovation Center Copenhagen A/S Micromirs
EP2217248B1 (en) * 2007-10-29 2016-11-30 Regulus Therapeutics Inc. Targeting micrornas for the treatment of liver cancer
EP2245199B1 (en) * 2008-02-01 2013-11-13 The General Hospital Corporation Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
US20110054009A1 (en) * 2008-02-28 2011-03-03 The Ohio State University Research Foundation MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders
WO2009111375A2 (en) * 2008-03-01 2009-09-11 Abraxis Bioscience, Llc Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
EP2268832A2 (en) * 2008-03-06 2011-01-05 Asuragen, INC. Microrna markers for recurrence of colorectal cancer
WO2009147525A1 (en) * 2008-06-04 2009-12-10 Karolinska Institutet Innovations Ab Skin cancer associated micrornas
US20100021734A1 (en) * 2008-07-22 2010-01-28 Covalent Materials Corporation Ceramic particles and producing method thereof
KR101031305B1 (ko) * 2008-07-23 2011-04-29 국립암센터 마이크로ｒｎａ-21 저해제를 포함하는 방사선 민감성증진용 조성물
US20100179213A1 (en) * 2008-11-11 2010-07-15 Mirna Therapeutics, Inc. Methods and Compositions Involving miRNAs In Cancer Stem Cells
AU2009322907B2 (en) * 2008-12-05 2016-05-05 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer

Similar Documents

Publication Publication Date Title
JP2011516032A5 (https=)
Bulk et al. Epigenetic dysregulation of KCa3. 1 channels induces poor prognosis in lung cancer
Duforestel et al. Glyphosate primes mammary cells for tumorigenesis by reprogramming the epigenome in a TET3-dependent manner
Huang et al. SET and MYND domain containing protein 3 in cancer
JP2011517932A5 (https=)
ES2742840T3 (es) Biomarcadores de micro-ARN para identificar el riesgo y/o diagnosticar tumor pulmonar
Chen et al. H2AK119Ub1 and H3K27Me3 in molecular staging for survival prediction of patients with pancreatic ductal adenocarcinoma
Meng et al. Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer
ES2772701T3 (es) Uso de nucleosomas libres de células como biomarcadores en muestras de esputo
Fong et al. MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency
Suri et al. Recent advances in minimally invasive biomarkers of OSCC: from generalized to personalized approach
Cheng et al. CREB1-induced lncRNA LEF1-AS1 contributes to colorectal cancer progression via the miR-489/DIAPH1 axis
Lin et al. MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma
Pan et al. miR-29b-3p increases radiosensitivity in stemness cancer cells via modulating oncogenes axis
Chien et al. Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior
Chen et al. Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation
Wang et al. MicroRNA-374b inhibits the tumor growth and promotes apoptosis in non-small cell lung cancer tissue through the p38/ERK signaling pathway by targeting JAM-2
Cai et al. High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma
Okada et al. Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma
Li et al. DNA demethylase TET2-mediated reduction of HADHB expression contributes to cadmium-induced malignant progression of colorectal cancer
Zhang et al. HTR1D regulates the PI3K/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenib
Zheng et al. MRTO4 enhances glycolysis to facilitate HCC progression by inhibiting ALDOB
Wu et al. PHLPP2 is regulated by competing endogenous RNA network in pathogenesis of colon cancer
Ding et al. TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L signaling
Li MiR-509-3-5p inhibits colon cancer malignancy by suppressing GTSE1